Caricain: A basis for enzyme therapy for coeliac disease
Gliadin, a glycoprotein present in wheat and other grass cereals, is a causative agent in coeliac disease. It is therefore important to find methods for the detoxification of gliadin. Lysosomal integrity is lost in patients with active coeliac disease but restored when gliadin is removed from the di...
Main Authors: | Hugh J. Cornell, Teodor Stelmasiak |
---|---|
Format: | Article |
Language: | English |
Published: |
Academy of Science of South Africa
2011-09-01
|
Series: | South African Journal of Science |
Subjects: | |
Online Access: | http://archive.sajs.co.za/index.php/SAJS/article/view/529 |
Similar Items
-
Caricain: A basis for enzyme therapy for coeliac disease
by: Hugh Cornell, et al.
Published: (2011-09-01) -
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first!
by: Michele Arigliani, et al.
Published: (2017-08-01) -
Digestibility of wheat alpha-amylase/trypsin inhibitors using a caricain digestive supplement
by: Angéla Juhász, et al.
Published: (2022-08-01) -
Evaluation of coeliac disease serological markers
by: leen K. Mustafa Kamil
Published: (2015-07-01) -
Tissue transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype - implications for the role of transglutaminase in coeliac disease
by: Dalleywater William J, et al.
Published: (2012-04-01)